The more tension there is about this, the more suspicion will grow. However, we don't want to get to that point. We want to work with you in the spirit of cooperation and confidentiality to avoid any erosion of trust in our institutions and in the pharmaceutical companies. I feel it's important to reiterate that point.
On March 23rd, 2023. See this statement in context.